BAK, BRBRKMACNPA4

HSBC cuts Braskem target to USD 1.50 for Braskem stock

Published on 10/17/2026 at 20:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter EBITDA reached USD 1.043 billion on August 14, 2026. Braskem stock last at BRL 4.04 on October 16, 2026, down 6.48 percent on B3.

Analyst pressure and trading date

  • HSBC reduced its Braskem target to USD 1.50 on September 28, 2026.
  • Second-quarter EBITDA reached USD 1.043 billion on August 14, 2026.
  • Braskem stock last stood at BRL 4.04 at 5:03 p.m. BRT on October 16, 2026, down 6.48 percent versus the B3 prior close.
  • Braskem is scheduled to report its next earnings on November 12, 2026.
BAK, BRBRKMACNPA4, Illustration mit AI erstellt.

HSBC cut its target for Braskem from USD 6.50 to USD 1.50 and downgraded the stock from Buy to Hold in a research note dated September 28, 2026, as reported by MarketBeat. Against the NYSE quotation of USD 1.66 on October 16, 2026, the USD 1.50 target is 10.67 percent below the price. Braskem stock last stood at BRL 4.04 at 5:03 p.m. BRT on October 16, 2026, down 6.48 percent versus the B3 prior close of BRL 4.32.

Second-quarter earnings provide support

Braskem reported consolidated earnings before interest, taxes, depreciation and amortization of USD 1.043 billion for the second quarter of 2026. The figure was published on August 14, 2026, in the company release carried by Braskem. Net income reached USD 664 million in the same quarter, while gross corporate debt stood at USD 10.4 billion on June 30, 2026.

The results were supported by wider chemical and petrochemical spreads, while the company reported net cash consumption of USD 15 million during the quarter. The combination gives investors a clear contrast: operating earnings improved, but leverage and the target reductions remain central to the stock picture.

Stock sits above its yearly low

The B3 quotation was 14.77 percent above its BRL 3.52 52-week low and 70.68 percent below its BRL 13.78 52-week high on October 16, 2026. Trading volume was 7,739,300 shares, compared with an average of 7,047,031 shares. Market capitalization was BRL 3.4 billion, and the price-to-earnings ratio was minus 0.60.

Comparison with peers

Braskem (B3, BRL): minus 6.48 percent, P/E minus 0.60, market capitalization BRL 3.4 billion
LyondellBasell Industries (NYSE, USD): plus 2.14 percent, P/E minus 57.67, market capitalization USD 20.7 billion
Westlake Corporation (NYSE, USD): minus 0.44 percent, P/E minus 6.58, market capitalization USD 8.1 billion

Next reporting date

Braskem is scheduled to release its next earnings report on November 12, 2026, according to Investing.com. The date gives investors the next fixed checkpoint for earnings, debt and the companys restructuring priorities.

Price and valuation remain central

HSBCs lower target leaves the USD 1.50 level below the October 16 NYSE quotation of USD 1.66, while the B3 price remains close to its yearly low in local-currency terms. Braskem combines a recent earnings improvement with a negative P/E ratio and a large distance from its 52-week high.

Braskem stock facts

  • Company: Braskem S.A.
  • ISIN: BRBRKMACNPA4
  • Ticker: BRKM5
  • Primary exchange: B3
  • Last price B3 (as of October 16, 2026, 5:03 p.m. BRT): BRL 4.04
  • Change versus B3 prior close: minus 6.48 percent
  • Market capitalization: BRL 3.4 billion (as of October 16, 2026)
  • 52-week range: BRL 3.52-13.78 (as of October 16, 2026)
  • Sector / Industry: Basic Materials / Chemicals
  • Next earnings date: November 12, 2026

Market context: Market report Bovespa.

More news and analyses on Braskem stock

Disclaimer...
en | BRBRKMACNPA4 | BAK | boerse | 70350257 | bgmi